HTG Molecular Diagnostics to Participate in the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference

September 26, 2022

https://www.globenewswire.com/news-release/2022/09/26/2522466/34580/en/HTG-Molecular-Diagnostics-to-Participate-in-the-Cantor-Fitzgerald-Oncology-Hematology-HemeOnc-Conference.html

TUCSON, Ariz., Sept. 26, 2022 (GLOBE NEWSWIRE) —  HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that management will participate in the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference at the Lotte New York Palace in New York City on Wednesday, September 28, 2022.

Read more at globenewswire.com

Related news for (HTGM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.